Worth reading
49Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
3096000
Shares (initial maximum)Wording
Conditional
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights (stock options)
Who receives how much
3,096,000 common shares (30,960 stock acquisition rights, 100 shares per right; this number may decrease depending on the number of applications and other factors)
91 of the Company's executive officers and employees: 30,960 rights
The lower thin line represents the existing number of shares to which these shares will be added.
Undetermined (the fair value per share calculated using the Black-Scholes model on the allotment date, multiplied by 100 shares)
Total issue value
Undetermined
Amount of funds to be raised
Total amount paid in: Undetermined. Estimated net proceeds: Not disclosed
Terms of the stock acquisition rights
Exercise price
¥1 per share. Subject to adjustment in accordance with any stock split or consolidation. Minimum exercise price: Not disclosed
Exercise period
From 1 August 2028 to 31 July 2033
Number of Stock Acquisition Rights
Total number to be issued: 30,960 rights. Number of rights remaining unexercised: Not disclosed
Reason for acquisition without consideration
When a corporate reorganization or other similar transaction is approved; when the rights can no longer be exercised under the exercise conditions; when the holder waives the rights; when the acquisition of all shares of a class of shares subject to a wholly call provision is approved; when certain share consolidations are approved; or when a demand for the sale of shares by a special controlling shareholder is approved
Categories and Number of Persons Covered
91 of the Company's executive officers and employees: 30,960 rights
Intended allottee's holding policy
The acquisition of the stock acquisition rights through transfer requires approval by the Company's Board of Directors. Other holding policies and lock-up arrangements: Not disclosed
Payment date
17 July 2026 (the allotment date for the stock acquisition rights; acquired through offsetting against compensation receivables)
Basis for determining the amount to be paid
The fair value per right will be calculated using the Black-Scholes model on the allotment date. The share price will be the closing price for regular trading of the Company's common shares on the Tokyo Stock Exchange on 17 July 2026, and the expected remaining life will be 2 years. The discount rate and premium rate: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights (stock options) |
| Number of shares to be issued or disposed of | 3,096,000 common shares (30,960 stock acquisition rights, 100 shares per right; this number may decrease depending on the number of applications and other factors) |
| Issue price and disposal price | Undetermined (the fair value per share calculated using the Black-Scholes model on the allotment date, multiplied by 100 shares) |
| Total issue value | Undetermined |
| Amount of funds to be raised | Total amount paid in: Undetermined. Estimated net proceeds: Not disclosed |
| Payment date | 17 July 2026 (the allotment date for the stock acquisition rights; acquired through offsetting against compensation receivables) |
| Intended allottee | 91 of the Company's executive officers and employees: 30,960 rights |
| Intended allottee's holding policy | The acquisition of the stock acquisition rights through transfer requires approval by the Company's Board of Directors. Other holding policies and lock-up arrangements: Not disclosed |
| Basis for determining the amount to be paid | The fair value per right will be calculated using the Black-Scholes model on the allotment date. The share price will be the closing price for regular trading of the Company's common shares on the Tokyo Stock Exchange on 17 July 2026, and the expected remaining life will be 2 years. The discount rate and premium rate: Not disclosed |
| Exercise price | ¥1 per share. Subject to adjustment in accordance with any stock split or consolidation. Minimum exercise price: Not disclosed |
| Exercise period | From 1 August 2028 to 31 July 2033 |
| Number of Stock Acquisition Rights | Total number to be issued: 30,960 rights. Number of rights remaining unexercised: Not disclosed |
| Reason for acquisition without consideration | When a corporate reorganization or other similar transaction is approved; when the rights can no longer be exercised under the exercise conditions; when the holder waives the rights; when the acquisition of all shares of a class of shares subject to a wholly call provision is approved; when certain share consolidations are approved; or when a demand for the sale of shares by a special controlling shareholder is approved |
| Categories and Number of Persons Covered | 91 of the Company's executive officers and employees: 30,960 rights |
Items this document does not state (14)
Estimated issuance expensesSpecific use of fundsDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To align the Company's performance with the benefits received by its executive officers and employees, thereby aligning their interests with those of shareholders and increasing their motivation to enhance corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.